In reaction to disappointing earnings/guidance: SGOC -56.8% (announced FY14 interim financial results: revenues decreased 70% to $34.1 mln), TESO -7.3% light volume (guides Q4 below consensus following oil price decline).
Other news: GILD -11.6% (Express Scripts (ESRX) agreed to make AbbVie's (ABBV) Hep C drug (Viekira Pak, approved on Friday) the exclusive treatment for most patients), OCN -10% (WSJ reports Chairman may resign amid settlement), NEWM-1.8% (files for $150 mln offering of common stock).
Other news: GILD -11.6% (Express Scripts (ESRX) agreed to make AbbVie's (ABBV) Hep C drug (Viekira Pak, approved on Friday) the exclusive treatment for most patients), OCN -10% (WSJ reports Chairman may resign amid settlement), NEWM-1.8% (files for $150 mln offering of common stock).